Prenatal exposures to phthalates among women in New York City and Krakow, Poland. by Adibi, Jennifer J et al.
Recent surveys have revealed that phthalate
exposures are widespread in the general U.S.
population [Blount et al. 2000b; Centers for
Disease Control and Prevention (CDC)
2003]. Based on one survey, women of repro-
ductive age (20–40 years of age) appear to be
more exposed to dibutyl phthalate (DBP)
than are other age groups (Blount et al.
2000b; Kohn et al. 2000), possibly due to the
volatilization and inhalation of phthalates
from a variety of commonly used cosmetics
and household products. These findings
prompted an investigation to characterize
phthalate exposures in two cohorts of preg-
nant women in New York, New York, and in
Krakow, Poland, as part of the research being
conducted by the Columbia Center for
Children’s Environmental Health. We used
48-hr personal air samples to measure exter-
nal exposures in all 60 subjects. Urinary
metabolites were used as a measure of internal
dose for 25 of the New York subjects.
Phthalates are a class of high production
volume chemicals (> 1 million tons produced
or exported into the United States per year)
that are commonly present in the home envi-
ronment. Phthalates have widespread uses as
plasticizers, emollients (skin softeners),
humectants (skin moisturizers), antifoaming
agents in aerosols, agents to prevent brittleness
and cracking in nail polishes, and sealants
[Agency for Toxic Substances and Disease
Registry (ATSDR) 1999; Center for the
Evaluation of Risks to Human Reproduction
(CERHR) 2000a, 2000b, 2000c; Houlihan
and Wiles 2000]. As of October 2000, the
U.S. Patent and Trademark Office had 309
patents registered for DBP use in cosmetics
(Houlihan and Wiles 2000). This includes
120 nail base coats, polishes, and enamels and
27 manicuring preparations (DiGangi et al.
2002). Phthalates are used in insect repellants,
shower curtains, hair sprays, and building
products (ATSDR 1999; CERHR 2000c). In
1995, diethyl phthalate (DEP) was reported
to be in 67 formulations as a solvent and as a
vehicle for fragrance and cosmetic ingredients
at concentrations ranging from 0.1% to 50%
(Scientiﬁc Committee on Cosmetic Products
and Non-food Products Intended for
Consumers 2002). Diethylhexyl phthalate
(DEHP) has been the primary plasticizer used
in polyvinyl chloride since the 1930s
(Woodward 1988).
Phthalates are released into the environ-
ment throughout the cycle of their production,
use, and disposal. The principal route of expo-
sure is assumed to be the ingestion of contami-
nated food products (CERHR 2000a, 2000b,
2000c). Phthalates are taken up into the food
chain and are present in meat, ﬁsh, and dairy
products (Petersen and Breindahl 2000). They
can migrate from plastic containers and wraps
into the fat layer of packaged foods (Sharman
et al. 1994). Off-gassing of phthalates from
products in the home can contribute to ambi-
ent air levels. Because of their lipophilicity,
phthalates are readily absorbed through the
skin. Inhalation and dermal absorption are
considered important direct routes of expo-
sure, although this is not well documented or
understood (Blount et al. 2000b; CERHR
2000b, 2000c).
Phthalate congeners with more than two
and fewer than eight carbon atoms are repro-
ductive and developmental toxicants of vary-
ing potencies (Gray et al. 2000; Heindel et al.
1989). Based on experimental evidence, DBP
and DEHP have been characterized as
endocrine disruptors acting through complex
pathways that generally do not involve the
androgen and estrogen receptors (Corton et
al. 1997; Davis et al. 1994a; Gray et al. 2000;
Lovekamp-Swan and Davis 2003; Mylchreest
et al. 1998). Experimental evidence indicates
that DEHP suppresses ovarian estradiol pro-
duction in adult females by inhibiting the
transcription of the enzyme aromatase (Davis
et al. 1994a, 1994b; Lovekamp and Davis
2001). This has negative effects on estrogen-
dependent processes such as ovulation and fer-
tility (Ema et al. 2000; Lovekamp-Swan and
Davis 2003). It is not clear how this estrogen
effect may interfere in the development of the
fetus or a woman’s ability to sustain a healthy
pregnancy. In male animals, DBP, DEHP,
and butyl benzyl phthalate (BBzP) act as
antiandrogens, causing decreased testosterone
production in the male fetus, which can result
in malformations in the external genitalia,
degeneration of the seminiferous tubules, and
reduced sperm production (Gray et al. 2000;
Sharpe 2001). DEP has not been shown to be
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Experimental evidence has shown that certain phthalates can disrupt endocrine function and induce
reproductive and developmental toxicity. However, few data are available on the extent of human
exposure to phthalates during pregnancy. As part of the research being conducted by the Columbia
Center for Children’s Environmental Health, we have measured levels of phthalates in 48-hr per-
sonal air samples collected from parallel cohorts of pregnant women in New York, New York,
(n = 30) and in Krakow, Poland (n = 30). Spot urine samples were collected during the same 48-hr
period from the New York women (n = 25). The following four phthalates or their metabolites
were measured in both personal air and urine: diethyl phthalate (DEP), dibutyl phthalate (DBP),
diethylhexyl phthalate (DEHP), and butyl benzyl phthalate (BBzP). All were present in 100% of
the air and urine samples. Ranges in personal air samples were as follows: DEP (0.26–7.12 µg/m3),
DBP (0.11–14.76 µg/m3), DEHP (0.05–1.08 µg/m3), and BBzP (0.00–0.63 µg/m3). The mean
personal air concentrations of DBP, di-isobutyl phthalate, and DEHP are higher in Krakow,
whereas the mean personal air concentration of DEP is higher in New York. Statistically signiﬁcant
correlations between personal air and urinary levels were found for DEP and monoethyl phthalate
(r = 0.42, p < 0.05), DBP and monobutyl phthalate (r = 0.58, p < 0.01), and BBzP and monoben-
zyl phthalate (r = 0.65, p < 0.01). These results demonstrate considerable phthalate exposures dur-
ing pregnancy among women in these two cohorts and indicate that inhalation is an important
route of exposure. Key words: endocrine disruption, exposure assessment, internal dose, personal air
monitoring, phthalates, prenatal exposures, urban, urinary metabolites. Environ Health Perspect
111:1719–1722 (2003). doi:10.1289/ehp.6235 available via http://dx.doi.org/ [Online 7 July 2003]
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(Gray et al. 2000; Lamb et al. 1987).
Phthalate monoester levels in the urine
have recently been validated as a reliable and
accurate biomarker of internal dose (Anderson
et al. 2001; Blount et al. 2000a). The objective
of the present study was to characterize phtha-
late exposures in pregnant women using per-
sonal air and urine measures (urine in a subset
of 25 women) collected within a 48-hr period.
Although these samples represent a snapshot of
exposures over a 9-month period, they provide
important information that will guide future
research to better understand the effects of
phthalates on pregnancy. This is the ﬁrst study
to report statistical correlations between phtha-
late diester levels measured in personal air and
urinary monoester metabolite levels.
Materials and Methods
Enrollment. Study protocols including eligibil-
ity requirements and comparability between
women who agreed to participate and those
who refused have been described in detail pre-
viously (Whyatt et al. 2002). Women 18–35
years of age were enrolled during pregnancy at
prenatal clinics in New York and Krakow. In
New York, recruitment was restricted to
women who were self-identified as African
American or Dominican and had resided in
northern Manhattan or the South Bronx for
≥ 1 year before pregnancy. In Krakow, because
the central aims of the study were to evaluate
the effects of ambient air pollution, the study
was restricted to women who had resided in
Krakow for at least 1 year within a 0.5-km
radius of two ambient air monitoring stations
with the highest and lowest pollution levels.
To control for known risk factors of adverse
birth outcomes, women were excluded if they
smoked cigarettes or used other tobacco prod-
ucts during pregnancy; used illicit drugs; had
diabetes, hypertension, or known HIV (human
immunodeﬁciency virus) infection; or had had
their ﬁrst prenatal visit after the 20th week of
pregnancy. The institutional review boards 
of Columbia University and Jagiellonian
University in Krakow approved the study. The
60 personal air samples selected for analysis as
part of the present study represent two separate
batches of air samples received by the labora-
tory and analyzed a posteriori for phthalates.
The New York batch was analyzed in October
2000, and the Krakow batch in June 2001.
Personal ambient air monitoring. The 48-
hr personal air monitoring was undertaken
during the second trimester of pregnancy for
Krakow and during the third trimester for
New York subjects. The women wore a small
backpack holding a personal ambient air mon-
itor during the daytime hours for 2 consecu-
tive days and kept the monitor near the bed at
night. The backpack was designed so that the
sampling inlet was positioned in the woman’s
breathing zone. Pumps operated continuously
at 2 L/min among Krakow subjects and 4
L/min among New York subjects, collecting
particles of ≤ 2.5 µm in diameter on a pre-
cleaned quartz microfiber filter, and semi-
volatile vapors and aerosols on a polyurethane
foam (PUF) cartridge backup. In New York,
the women were monitored between March
and July 2000. In Krakow, they were moni-
tored between November 2000 and March
2001.
Phthalates in air monitoring samples. The
air monitoring samples were brought to the
laboratories (the Mailman School of Public
Health or the Jagiellonian University), inven-
toried, and frozen. Once per month, air-moni-
toring samples were shipped on dry ice to
Southwest Research Institute, where they were
stored at –12°C. Samples were analyzed in sep-
arate batches for each city. The PUF and ﬁlter
were soxhlet extracted with 6% diethyl ether in
hexanes, and the extract was concentrated to
1.0 mL. Gas chromatography–mass spectrom-
etry (MS) analysis for the ﬁve phthalates was
performed using an Agilent 6890 gas chro-
matograph with a DB-5.625 column (30 m ×
25 mm inner diameter) column and an Agilent
5973 Mass Selective Detector in selected ion
monitoring mode (Agilent Technologies, Palo
Alto, CA, USA). DEHP, DBP, BBzP, DEP,
and di-isobutyl phthalate (DIBP) were quanti-
fied by the internal standard method using
deuterium-labeled polycyclic aromatic hydro-
carbon (PAH) as the internal standard. The
relative standard deviation of the initial ﬁve-
point standard calibration was maintained
within 30% for each analyte, except for BBzP
(within 31%) and DEHP (within 45%) for
some Krakow samples. A continuing calibra-
tion standard was processed at the beginning
and end of each sequence of 15 extracts. The
difference of the relative response factor of the
continuing calibration standards differed from
the initial calibration average by < 40%, except
for BBzP (within 43%) and DEHP (within
61%) for some Krakow samples. Multiple
dilutions were usually needed to bring all ana-
lytes within the linear calibration range.
Laboratory blank samples were used to
assess the level of phthalate contamination
inherent to the analytic process of PUF car-
tridges being used in this study. The laboratory
provided values for the phthalate congeners
measured in three blank cartridges analyzed
along with the New York samples and four
blank cartridges analyzed with the Krakow
samples. Arithmetic means for the quality
assurance/quality control samples were calcu-
lated for each congener and then subtracted
from the sample values. The blank-subtracted
mass value was then divided by the total vol-
ume of air drawn for each sample to give the
concentration in nanograms per cubic meter.
Mean blank levels were considerably lower
than the analyte levels, but those of BBzP and
DEHP exceeded 10% of the mean sample
mass. The relative ranks of the congeners were
unchanged before and after adjustment.
Urine sample collection. A spot urine
sample was collected from the New York sub-
jects at the conclusion of the personal moni-
toring and delivered to the laboratory where it
was frozen at –70°C. Within 5 months of col-
lection, the samples were sent to the National
Center for Environmental Health laboratory
at the Centers for Disease Control and
Prevention (CDC) in Atlanta, Georgia, where
they were processed and analyzed for a variety
of biomarkers. The urine samples for New
York subjects were matched by identiﬁcation
number to the personal air samples and ana-
lyzed where volume was sufﬁcient.
Urine sample analysis. The method for
analysis of urine samples was described previ-
ously (Blount et al. 2000a). The urine was ﬁrst
treated with glucuronidase enzyme in order to
deconjugate the monoester metabolites. They
were then extracted twice with Oasis HLB
solid-phase extraction cartridges (Waters,
Milford, MA, USA) and resuspended in the
mobile phase. The samples were analyzed
using high-performance liquid chromatogra-
phy–tandem MS. 4-Methylumbelliferone was
used as a quality control measure for the
deconjugation step. Urinary creatinine was
measured with an ASTRA analyzer (Beckman
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Table 1. Concentrations (µg/m3) of phthalate diesters detected in 100% of 48-hr personal air samples in two
populations of pregnant women.
New York (n = 30) Krakow (n = 30)
Phthalate diester Median Mean ± SD Range Median Mean ± SD Range
DBP  0.40 0.58 ± 0.73 0.11–4.1 2.3 2.9 ± 2.5 0.75–15
DEP 2.7 3.0 ± 1.3 1.5–7.1 0.84 1.0 ± 0.67 0.26–2.9
DIBP  0.37 0.42 ± 0.27 0.03–1.3 0.81 1.0 ± 1.4 0.31–8.1
DEHP  0.22 0.22 ± 0.10 0.05–0.41 0.37 0.43 ± 0.24 0.08–1.1
BBzP 0.04 0.10 ± 0.15 0.01–0.63 0.02 0.04 ± 0.04 0.00–0.19
Figure 1. Comparison of geometric means of phtha-
lates in 48-hr personal air samples.
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New York
KrakowCoulter, Palo Alto, CA, USA) based on the
Jaffe rate reaction. Creatinine (reported in
micrograms per deciliter) was used to adjust for
variability in urine dilution. Creatinine excre-
tion changes during pregnancy may have an
effect on the validity of creatinine adjustment
in the data analysis. However, in this data set,
the results were essentially the same whether
the data were analyzed with or without creati-
nine adjustment. Measures were taken to elim-
inate phthalate contamination from the
laboratory environment, including substitution
of certain materials that were shown to contain
phthalates. Method blanks were used to moni-
tor contamination. If a blank had > 5 ppb of
any phthalate analyte, all the analytical results
for that day were rejected until the source of
contamination was identiﬁed.
Urine quantity was adequate to measure
phthalate metabolite levels in 25 of 30 New
York subjects for whom there were correspond-
ing personal air samples. Eight monoester
metabolites were quantiﬁed, including mono-
ethylhexyl phthalate (mEHP), monobenzyl
phthalate (mBzP), monobutyl phthalate
(mBP), monoethyl phthalate (mEP), mono-
cyclohexyl phthalate (mCHP), mono-n-octyl
phthalate (mOP), mono-isononyl phthalate
(mINP), and monomethyl phthalate (mMP).
Where the values were below the limit of
detection, they were set to one-half the limit of
detection for that congener.
Statistical analyses. We used SPSS for
Windows 11.1 (SPSS Inc., Chicago, IL, USA)
for the calculation of descriptive statistics and
Spearman’s rank correlation coefficients.
Statistical signiﬁcance is set at a p-value < 0.05.
The exposure and urine data are both nonnor-
mally distributed and right-skewed. They were
analyzed using nonparametric methods such
as Spearman’s rank. Geometric means are
used to visually compare the ﬁve most preva-
lent phthalates in the personal air of the
women in New York and Krakow using bar
graphs generated by Excel (version 9.0;
Microsoft, Redmond, WA, USA). Blank
adjustments for the personal air data and
creatinine adjustments for the urinary
metabolite data were done in SPSS.
Results
The New York sample is 70% Dominican or
Dominican American and 30% African
American. The Krakow women are 100%
ethnically Polish. The New York study popu-
lation can be characterized as low income,
whereas the Krakow population is middle
income by country-specific standards. The
mean age of the New York women is 22 years
(range, 18–31 years), and the Krakow mean
age is 27 (range, 18–34 years).
The ﬁve congeners listed in Table 1 were
detected in 100% of the air samples analyzed.
Figure 1 shows the relative distributions of
the five congeners detected in air in New
York and Krakow. DEP and DBP are the two
most prevalent phthalates in both New York
and Krakow, although their relative propor-
tions are reversed. DIBP and DEP are present
in approximately equal amounts in Krakow.
Descriptive statistics for the four phthalates
detected in 100% of urine samples are summa-
rized in Table 2. As in the personal air samples,
mEP is present in the highest concentration,
followed by mBP. Results for four of the con-
geners analyzed (mCHP, mOP, mINP, and
mMP) are not reported because they were
largely nondetected values. Concentrations of
the three monoesters in urine are all < 1 µg/g
creatinine.
The correlations between personal air and
urinary metabolite measurements for the New
York women are shown in Table 3. A signiﬁ-
cant correlation between personal air and uri-
nary measures were seen for BBzP (r = 0.65,
p < 0.01), DBP (r = 0.58, p < 0.01), and DEP
(p = 0.42, p < 0.05). DEHP, a larger mole-
cule, is not significantly correlated with the
internal dosimeter.
Discussion
These are the first data to demonstrate that
pregnant women in New York and Krakow
are exposed to a range of phthalates in their
personal environments. Four phthalates were
detected in 100% of the samples in New York
and Krakow. DEP and DBP are present in the
highest concentrations in both the air and
urine. DIBP is the next highest congener in
both cities.
Inhalation appears to be a signiﬁcant route
of exposure, given the high correlations
between air and urine measures for DEP,
DBP, and BBzP. This counters the general
belief that ingestion of contaminated food
products is the most signiﬁcant exposure path-
way (CERHR 2000a, 2000b, 2000c) and sug-
gests that inhalation and possibly dermal
absorption may also be determining a woman’s
exposure. The lack of a correlation between air
and urine for DEHP and BBzP may corre-
spond to pharmacokinetic differences between
the shorter and longer chain congeners.
For the sake of comparing phthalate
exposure levels in pregnant women with
those in the general population, the New
York sample values are compared with phtha-
late monoester concentrations generated as
part of the 1999–2000 sampling of the
National Health and Nutrition Examination
Survey (NHANES) conducted by the CDC
(2003). The purpose of these qualitative
comparisons is to identify possible differences
in phthalate exposure between pregnant
women and the general population. The
NHANES sample includes 2,541 nonpreg-
nant women, pregnant women, men, and
people of different age and racial/ethnic
groups. These comparisons do not control for
potential confounders such as geographic
location, diurnal variation in metabolite lev-
els, or season of sample collection. Another
comparison is made of mBP levels in the New
York women to levels in all females (≥ 6 years
of age) in the NHANES sample.
Based on a crude comparison, the New
York women are receiving exposures to DBP
above the background levels for the United
States. mBP levels in urine reported here are
elevated 30–70% across percentiles compared
with those seen in urine samples collected from
the general population (CDC 2003). The
median creatinine-adjusted level in the New
York women is 2-fold higher than in the
NHANES sample (42.6 vs. 21.9 µg/g creati-
nine) (CDC 2003). Compared with all females
in the NHANES sample (n = 1,326) who were
≥ 6 years of age, the median mBP concentra-
tion in the New York women is 1.5-fold
higher (42.6 vs. 28.6 µg/g creatinine). Levels of
the other three urinary metabolites (mEP,
mEHP, and mBzP) are similar between the
New York and NHANES subjects. 
These data do not allow for conclusions on
potential sources of phthalates in these
women’s environments, because the samples
were analyzed a posteriori and individual-level
information on cosmetic use and other lifestyle
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Table 2. Creatinine-adjusted phthalate monoester concentrations (µg/g creatinine) detected in 100% of
urine samples in New York subjects (n = 25).
Monoester metabolite Median Mean ± SD Range
mEP 236 690  ± 1.43  × 103 26.7–5.52 × 103
mBP 42.6  54.4  ± 24.5 21.3–105
mBzP 12.1 26.0 ± 28.2 5.60–120
mEHP 4.60 40.5  ± 98.4 1.80–449
Table 3. Spearman’s rank correlation coefﬁcients between personal air diester concentrations and urinary
monoester metabolites in a 48-hr period in the third trimester of pregnancy in New York (n = 25).
DEHP BBzP DBP DEP
mEHP 0.37 — — —
mBzP — 0.65** — —
mBP — — 0.58* —
mEP — — — 0.42*
*p < 0.05; **p < 0.001.factors was not collected. Correlations with
demographic and proxy exposure variables were
examined, but no clear trends emerged, largely
because of small cell sizes across categories. To
test the hypothesis that cosmetic use is driving
these exposure levels, survey instruments are
being incorporated into existing epidemiologic
studies to gather detailed information on cos-
metic use, timing of use in relation to sample
collection, and even brand name and dose
information on the cosmetics used.
There are limitations to the extrapolation
of the ﬁndings to estimates of exposure levels
at the population level. The sample size is
small, making it difficult to draw statistical
inferences. Estimates are inﬂuenced by a few
extreme values. The comparisons between
exposure levels in New York and Krakow
should be viewed as crude and unadjusted for
potential confounders including differences in
the timing of the urine samples, major sea-
sonal differences in sampling between the two
cities, and differences in ventilation of the
women’s apartments.
The New York sample is composed of
Dominican and African-American women gen-
erally with low income and low educational 
status. Therefore, conclusions cannot be drawn
on metabolite levels among all women. By lim-
iting the population to two racial/ethnic
groups, the ability to study genetic polymor-
phisms speciﬁc to these populations and their
relation to phthalate metabolism and endocrine
disruption is increased. Polymorphisms such as
the 5-α reductase deficiency in Dominican
women may be of particular interest to under-
standing effects of in utero phthalate exposure
on the male fetus (Cai et al. 1996; Katz et al.
1995). If racially determined genetic factors
prove to be important, the ability to generalize
these ﬁndings to women of other races is lost.
The estimates of urinary metabolite levels
are also crude and unadjusted for factors such
as enzymatic differences and diurnal variation
in phthalate metabolism. Comparisons with
other study populations are also not adjusted
for the degree to which phthalate metabolism
changes during pregnancy and other potential
confounders such as geographic location,
occupation, age differences, cosmetic use, and
dietary patterns.
Nonetheless, the evidence indicates that
pregnant women in New York and Krakow
are experiencing a range of exposure levels to
phthalates with some extreme values that may
be associated with a biologic response. The
New York women appear to be exposed at lev-
els above background levels in the United
States, which may have implications for their
pregnancy and/or the fetus. These results
require further investigation. A molecular epi-
demiologic study is being carried out to more
thoroughly characterize exposures in these two
cohorts and to incorporate placental markers
of in utero endocrine disruption that may be
related to placental function and pregnancy
outcomes.
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